IL28RApolymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

(2012) A. Lopez de Lapuente et al.   JOURNAL OF NEUROIMMUNOLOGY

Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients

(2012) Montserrat de Castellarnau et al.   PLoS One

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

(2011) Pablo Labarga et al.   AIDS

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients

(2011) Juan A. Pineda et al.   AIDS

The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patients

(2011) María López-Diéguez et al.   AIDS

Redefining Baseline Demographics: The Role of Genetic Testing in Hepatitis C Virus Infection

(2011) Jacinta A. Holmes et al.   Clinics in Liver Disease

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population

(2011) Qian Cui et al.   INFECTION GENETICS AND EVOLUTION

Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4

(2011) A. Rivero-Juarez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacogenetics of hepatitis C

(2011) V. Soriano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection

(2011) H.-Y. Rao et al.   JOURNAL OF VIRAL HEPATITIS

Induction and function of type I and III interferon in response to viral infection

(2011) David E Levy et al.   Current Opinion in Virology

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C

(2010) Albert Friedrich Stättermayer et al.   Clinical Gastroenterology and Hepatology

Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV

(2010) Jose Medrano et al.   CLINICAL INFECTIOUS DISEASES

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

(2010) Alexander J. Thompson et al.   GASTROENTEROLOGY

Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C

(2010) Michael T. Dill et al.   GASTROENTEROLOGY

Hepatitis C pharmacogenetics: State of the art in 2010

(2010) Nezam H. Afdhal et al.   HEPATOLOGY

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1

(2010) Amy Strange et al.   NATURE GENETICS

IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients

(2010) Ester Aparicio et al.   PLoS One

Coinfection With HIV-1 and HCV—A One-Two Punch

(2009) Arthur Y. Kim et al.   GASTROENTEROLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Management of Chronic Hepatitis C Virus Infection in HIV‐Infected Patients

(2008) Stanislas Pol et al.   CLINICAL INFECTIOUS DISEASES

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY